Research Analysts Issue Forecasts for Enovix FY2025 Earnings

Enovix Co. (NASDAQ:ENVXFree Report) – Stock analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for shares of Enovix in a report issued on Thursday, May 1st. Cantor Fitzgerald analyst D. Soderberg now anticipates that the company will post earnings per share of ($0.90) for the year, down from their prior estimate of ($0.83). Cantor Fitzgerald currently has a “Overweight” rating and a $30.00 price target on the stock. The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share.

Enovix (NASDAQ:ENVXGet Free Report) last announced its earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The company had revenue of $9.72 million during the quarter, compared to the consensus estimate of $8.77 million.

A number of other equities analysts also recently issued reports on ENVX. TD Securities lowered their price target on Enovix from $10.00 to $7.00 and set a “hold” rating on the stock in a research report on Thursday, May 1st. Craig Hallum dropped their price target on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Benchmark reduced their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, April 15th. B. Riley dropped their target price on shares of Enovix from $17.00 to $12.00 and set a “buy” rating on the stock in a research report on Tuesday, April 29th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Enovix from $10.00 to $9.00 and set an “overweight” rating for the company in a research report on Thursday, May 1st. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $17.27.

Read Our Latest Report on Enovix

Enovix Stock Down 4.1 %

ENVX stock opened at $6.09 on Monday. Enovix has a 12 month low of $5.27 and a 12 month high of $18.68. The company has a market capitalization of $1.17 billion, a P/E ratio of -4.20 and a beta of 1.99. The firm’s fifty day simple moving average is $7.17 and its 200-day simple moving average is $9.28. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61.

Insiders Place Their Bets

In other Enovix news, CEO Rajendra K. Talluri sold 300,000 shares of the business’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the transaction, the chief executive officer now owns 2,045,301 shares in the company, valued at approximately $19,123,564.35. The trade was a 12.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 15.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ENVX. Lpwm LLC acquired a new position in shares of Enovix during the 4th quarter worth $549,000. Vanguard Group Inc. increased its holdings in Enovix by 15.1% in the fourth quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company’s stock valued at $171,458,000 after buying an additional 2,063,631 shares in the last quarter. Haven Private LLC purchased a new position in Enovix in the fourth quarter valued at about $454,000. Register Financial Advisors LLC boosted its stake in shares of Enovix by 172.8% during the 4th quarter. Register Financial Advisors LLC now owns 174,850 shares of the company’s stock worth $1,901,000 after acquiring an additional 110,750 shares in the last quarter. Finally, Amundi grew its holdings in shares of Enovix by 360.8% in the 4th quarter. Amundi now owns 235,369 shares of the company’s stock worth $2,558,000 after acquiring an additional 184,294 shares during the period. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Earnings History and Estimates for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.